Search results
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 3 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 2 days agoNet product sales plummeted by 91% compared to Q1 2023. This downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines....
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo Finance· 3 days agoModerna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines ...
Moderna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall By Investing.com
Investing.com· 3 days agoModerna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 3 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 3 days agoThe Cambridge, Massachusetts-based drugmaker reaffirmed that it expects to receive approval from regulators for its respiratory syncytial virus (RSV) vaccine in time for it ...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 3 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 4 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
Cancer vaccines are having a renaissance
Technology Review· 3 days agoPersonalized cancer vaccines like the ones Moderna and BioNTech are developing are tailored to each patient’s particular cancer. Together these neoantigens ...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 3 days agoDate: May 02, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Moderna Inc (NASDAQ:MRNA) reported ...
